IRF1
IRF1 (interferon regulatory factor 1, also known as MAR) is a transcriptional regulator and tumour suppressor of the IRF family. It activates and represses target genes in innate and acquired immune responses, cell proliferation, apoptosis and the DNA damage response. Browse Assay Genie's current range of IRF1 research reagents below, or read on for the biology behind the target.
IRF1 is a transcriptional regulator that shows a wide functional range in controlling cellular responses. It can act as both an activator and a repressor, regulating target genes by binding to an interferon-stimulated response element (ISRE) in their promoters. It regulates transcription of interferon (IFN) and IFN-inducible genes, the host response to viral and bacterial infection, genes expressed during haematopoiesis, inflammation and immune responses, cell cycle control, and growth arrest and programmed cell death after DNA damage. IRF1 competes with the transcriptional repressor ZBED2 for binding to a common consensus sequence in gene promoters.
Activated targets span several programmes: anti-viral genes such as RIGI, ZBP1, OAS1/2, EIF2AK2/PKR and RSAD2/viperin; antibacterial genes such as GBP2, GBP5 and NOS2/iNOS; anti-proliferative and apoptotic genes such as TP53, CDKN1A, BBC3/PUMA and caspases 1, 7 and 8; and antigen presentation genes including TAP1, PSMB9, B2M and CIITA. It represses genes including BIRC5/survivin, CCNB1, CCNE1, CDK1, CDK2, CDK4, FOXP3, IL4 and TLR4. IRF1 also stimulates p53-dependent transcription by enhancing recruitment of EP300, which increases p53 acetylation.
In immunity, IRF1 affects NK cell maturation and activity, macrophage production of IL-12, Th1 development and CD8+ T-cell maturation. It is also implicated in dendritic cell differentiation and in suppressing regulatory T cell development, and has an essential role in IFN-gamma-dependent immunity to mycobacteria. As a tumour suppressor it antagonises tumour cell growth and stimulates immune responses against tumour cells. Defects in the IRF1 gene have been associated with gastric cancer, myelogenous leukaemia and lung cancer. The protein is localised to the nucleus and cytoplasm, and mouse and rat orthologs (Irf1) exist.
IRF1 regulates IFN and IFN-inducible genes, making it a central readout for studying interferon-driven transcriptional responses.
IRF1 influences NK maturation, macrophage IL-12 production, Th1 development and CD8+ T-cell maturation.
IRF1 suppresses tumour cell growth and stimulates anti-tumour immunity; defects are linked to gastric cancer, myelogenous leukaemia and lung cancer.
IRF1 contributes to growth arrest, programmed cell death and DNA repair gene regulation after DNA damage, partly via p53 stimulation.
IRF1 is a transcription factor that binds the interferon-stimulated response element in gene promoters to activate or repress targets. It regulates anti-viral and antibacterial responses, antigen presentation, cell cycle control and apoptosis, and it acts as a tumour suppressor.
The HGNC-approved name is interferon regulatory factor 1, and MAR is a listed alias. UniProt names the protein interferon regulatory factor 1. The IRF1 gene belongs to the interferon regulatory factors gene group, and the protein belongs to the IRF family.
Mouse and rat both have an Irf1 ortholog, so research can be carried out in these models; check the datasheet of any product for its validated reactivity. Defects in the human gene have been associated with gastric cancer, myelogenous leukaemia and lung cancer.
Other interferon regulatory factor family members with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P10914; product specifications from Assay Genie datasheets.